Opioid Crisis Hidden Truths

This FDA Incompetence Allowed Opioid Addiction to be Legal

4 min · 16 de may de 2026
Portada del episodio This FDA Incompetence Allowed Opioid Addiction to be Legal

Descripción

The US opioid crisis, fueled by FDA inadequacy, lack of guidelines, incompetence, overproduction, addiction, street sales, and addiction has led to alarming overdose deaths. The DEA combats this, but fentanyl's surge overwhelms efforts. Neuroscience shows opioid receptor vulnerability, and historical opium wars warned of dangers. Veterans and PTSD sufferers are especially at risk, with limited treatment. CDC alarms are raised, but FDA's slow regulation hinders progress. Narcan saves lives but is a temporary fix. Examining root causes and the FDA's role is key to a comprehensive solution.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Opioid Crisis Hidden Truths!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

44 episodios

episode Ask the Right Questions: FDA Ombudsman and the Future of the OPIOID CRISIS artwork

Ask the Right Questions: FDA Ombudsman and the Future of the OPIOID CRISIS

The opioid crisis deeply impacts the US with rising overdose deaths fueled by fentanyl. We are tasked by the FDA with finding solutions to move past this OPIOID CRISIS!, and the FDA ombudsman plays a crucial, overlooked role. Examining opioid addiction science, brain models, and receptors can lead to solutions. Current guidelines may be insufficient, requiring bypassing bureaucracy for change. Observing near-death experiences and naloxone highlights the crisis's gravity. Rethinking our approach, with the FDA ombudsman key, combining law enforcement, neuroscience, and public health can create a future free from this crisis. Adrenaline and depression linked to addiction need a holistic approach using the latest science. FDA and CDC guidelines can form a framework for a new paradigm. The crisis's future depends on asking pertinent questions and seeking innovative solutions, with the FDA ombudsman integral.

11 de jun de 20263 min